Nanospectra Biosciences, Inc. is commercializing a particle-based therapy for the selective and precise thermal destruction of solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. This medical device, AuroLase™ Therapy, is broadly applicable to most solid tumors, and we have a pending application with FDA for an Investigation Device Exemption (IDE) to conduct the first clinical trial in patients with head and neck cancer. AuroLase Therapy utilizes
Hip VISE comes complete with all elements needed to
position the patient for hip and pelvic surgery:
Hip VISE Positioning Frame,
Posterior & Anterior Positioning Pads,
Work Platform,
Four Grip-Lok™ Clamps,
Arm Support,
Storage/transport Dolly.
